Skip to main content
Fig. 1 | Journal of Ovarian Research

Fig. 1

From: MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer

Fig. 1

Expression of miR-29c-3p in OC. a MiR-29c-3p was lowly expressed in OC tissues compared with normal samples (P = 0.0238 for GSE119055). b The miR-29c-3p expression was clearly decreased in primary OC tissues than that in normal OC tissues (P = 0.0040 for GSE83693). c The expression of miR-29c-3p in recurrent OC tissue was markedly declined than that in primary OC tissues (P = .0044 for GSE83693). d qRT-PCR assay illustrated that the expression of miR-29c-3p in two OC cells (SKOV3 and OVCAR3) was down-regulated than that in corresponding normal cell (IOSE80). **P < 0.01. e Down-regulation of miR-29c-3p was interrelated to unfavourable outcomes in OC (P = 0.041)

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us